$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
12:56pm, Monday, 04'th Mar 2024
The approval is based on data from a late-stage study wherein treatment with J&J's (JNJ) Rybrevant plus chemotherapy reduced the disease-progression risk or death by 61% in certain NSCLC patients.
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
06:25am, Monday, 04'th Mar 2024
Investing in dividend kings is about keeping things simple. A distinguishing feature of these companies is a rock-solid balance sheet that allows them to demonstrate unwavering commitment to building
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2030?
08:14am, Sunday, 03'rd Mar 2024
Johnson & Johnson has been leaning on acquisitions lately to strengthen its portfolio of products. The company expects to grow at an annual rate of around 5% or better until the end of the decade.
FDA approves J&J's combination therapy for a type of lung cancer
02:47pm, Friday, 01'st Mar 2024
The U.S. health regulator on Friday approved Johnson & Johnson's therapy in combination with other chemotherapies for the first-line treatment of a type of lung cancer.
Don't Panic! 7 Smart Stocks to Buy if the Markets Take a Tumble.
02:26pm, Thursday, 29'th Feb 2024
While the equities sector roars higher, it's never a bad idea to consider stocks to buy for a down market. No, I'm not prognosticating an imminent calamity.
Want $1,000 in Ultra-Safe Annual Dividend Income? Invest $19,000 Into the Following 3 Time-Tested Dividend Kings.
05:06am, Thursday, 29'th Feb 2024
Dividend stocks have handsomely outpaced the average annual return of non-payers over the past 50 years. Wall Street's Dividend Kings -- companies that have increased their payouts for at least 50 con
Johnson & Johnson Stock Has 33% Upside, According to 1 Wall Street Analyst
05:49am, Wednesday, 28'th Feb 2024
Johnson & Johnson now has a slimmer business model than before. It may be launching a handful of products this year as well.
Nearing Retirement? These Stocks Are as Cautious as They Come
05:44am, Wednesday, 28'th Feb 2024
UnitedHealth is a central cog in U.S. healthcare. Johnson & Johnson is arguably the world's most financially secure company.
Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know
06:51pm, Tuesday, 27'th Feb 2024
Johnson & Johnson (JNJ) concluded the recent trading session at $160.98, signifying a +0.12% move from its prior day's close.
7 Dividend Stocks Every Investor Should Own to Survive a Market Crash
05:12pm, Tuesday, 27'th Feb 2024
There are many paths to profit on Wall Street but one of the best strategies is investing in dividend stocks. Over long periods dividend-paying stocks have outperformed those that don't pay one.
Should You Pick Johnson & Johnson Stock At $160?
07:00am, Tuesday, 27'th Feb 2024
Johnson & Johnson (NYSE: JNJ) reported its Q4 results last month, with revenues and earnings marginally above the street estimates. The company reported revenue of $21.4 billion and adjusted earnings
3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition
12:53pm, Monday, 26'th Feb 2024
Dividend stocks are an ideal way to build wealth. Whether you are just starting your investment journey or looking for ways to enjoy steady returns on your investment, investing in dividend stocks is
7 Stocks to Buy Now if You Think the S&P 500's Winning Streak Will Continue
02:30pm, Sunday, 25'th Feb 2024
This earnings season has been explosive. Several stocks hit all-time highs, including Nvidia (NASDAQ: NVDA ).
2 Top Dividend Stocks To Watch Today
09:53am, Friday, 23'rd Feb 2024
Check out these two top dividend stocks to watch in the stock market today.
Why Is Johnson & Johnson (JNJ) Down 0.2% Since Last Earnings Report?
12:36pm, Thursday, 22'nd Feb 2024
Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock?
Sign In
Buy JNJ